You are here

Press Releases

Press Release | October 8, 2014
Danielle Blake
dblake@advamed.org

The Advanced Medical Technology Association (AdvaMed) today bestowed the second annual AdvaMed Lifetime Achievement Award to Medtronic co-founder Earl Elmer Bakken, creator of the first wearable, battery-operated external pacemaker. 

Press Release | October 6, 2014
Wanda Moebius
wmoebius@advamed.org

A new study by the Analysis Group shows that private insurers are rapidly adopting new provider payment models – including pay-for-performance and financial risk-sharing arrangements – and tightening coverage evidence requirements for new technologies.

Statement | September 30, 2014
Wanda Moebius
wmoebius@advamed.org

“AdvaMed supports appropriate disclosure of relationships between medical technology companies and physicians."

Statement | September 30, 2014
Mark E. Brager
mbrager@advamed.org

“AdvaMedDx appreciates FDA’s release of draft guidance on a risk-based approach to the regulation of LDTs and looks forward to reviewing and providing comments. LDTs are increasingly being used to diagnose and guide the treatment of potentially life-threatening conditions.

Press Release | September 19, 2014
Wanda Moebius
wmoebius@advamed.org

“Repealing this tax will help ensure the U.S. maintains its global leadership in this high-tech manufacturing sector and advance the development of new cures and treatments,” said Stephen J. Ubl, President and CEO of AdvaMed. 

Press Release | September 18, 2014
Mark Brager
MBrager@advamed.org

“AdvaMed commends the call from APEC’s Small and Medium Enterprise (SME) ministers to double the number of codes of ethics in the region for the medical device and biopharmaceutical sectors by 2015.

Press Release | September 16, 2014
Mark Brager
MBrager@advamed.org

Stephen J. Ubl, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued a statement on the release of an omnibus jobs bill (H.R. 4) in the U.S. House of Representatives which includes language to repeal the medical device excise tax.

Press Release | September 9, 2014
Wanda Moebius
wmoebius@advamed.org

In the written testimony provided to the committee, Fish said, “For years, stakeholders have recognized the inadequacy of current oversight of LDTs and called for FDA to enforce existing regulations that apply to LDTs just as they do to all other diagnostics.” 

Press Release | August 21, 2014
Wanda Moebius
wmoebius@advamed.org

“We are pleased Rep. Maffei helped lead our discussion on the importance of supporting medical technology companies at the federal level,” 

Statement | July 31, 2014
Wanda Moebius
wmoebius@advamed.org

“AdvaMedDx’s membership supports a modernized and flexible approach to the review process for diagnostics. Such a review process should create a reasonable pathway to market and advance patient care by promoting timely access to innovative technologies."

Pages